chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received Pfizer COVID vaccine on 1/30/21 and 2/26/21. On 2/8/22, patient admitted to our inpatient facility after dialysis session with acute encephalopathy likely secondary to acute viral syndrome/COVID pneumonia with fever and positive COVID status. As of today (2/10/22), patient is still admitted in our med/surg unit.
Pt woke up with fever & chills, lasting 3 days. Temp went to 104. First day, could not get warm. Second day, fever & chills. No nausea or diarrhea, not hungry, ate very little. Fourth day, began to feel better. Pt missed 2 days due to this event. Pt has been evaluated by a physician or health care professional for this event. No ANTHRAX shots since the reported event. Dr could not say whether the sickness was caused by the shot or just a coincidence, the flu like symptoms came at the same time. He did say that Pt could resume the shots this summer and if the symptoms appeared again, further evaluation should be done before + take another shot.
Vaccine hurt when originally being administered; Administered only the adjuvant/on 7/9; Administered only the adjuvant/on 7/9/Full dose/given 7/15; This case was reported by a other health professional via sales rep and described the occurrence of injection site pain in a 51-year-old male patient who received Herpes zoster (Shingrix) (batch number d4pa4, expiry date unknown) for prophylaxis.   On 9th July 2021, the patient received Shingrix. On 9th July 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain, inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided are as follows: The patient received only adjuvant component of Shingrix in his right deltoid, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The office gave a full dose of Shingrix in left deltoid on 15th July 2021. No adverse event was reported  but only mentioned it hurt during original vaccination. The reporter consented to follow-up.
Information has been received from a physician concerning a pt who at 12 months old, was vaccinated with a dose of varicella virus vacciene live. Subsequently, the pt experienced chicken pox. Unspecified medical attention was sought. No product quality complaint was involved. Additonal information is not expected.
Approximately one day after received the shot, started with mild fever, fatigue, chills, dry cough.  Lasted from mid-day Saturday to mid day Monday.
1st 24 hrs post injection; fever, nausea, vomiting with extreme irritability.  Symptoms persist for 72 hrs, then return idiopathically >/~ 4 mos.  Speech regression & withdrawal with minimal to no verbal communication.  Speaking prior to event.  Dates on this form are correct & this supercedes the prior report.  My info is now correct.
On December 3, 2022, I was extremely tired. The next day I woke with body aches and a bad headache. In general, I just felt ill. I took a home test and was positive COVID-19. On Monday and Tuesday, I still felt very ill and started to have a runny nose and a cough and diarrhea. On Wednesday I began to feel better. The rest of the week I didn't feel worse, but I didn't feel much better. On the 11th and 12th, I felt better. Yesterday I felt terrible again because I didn't have any energy, but I feel better today. I was prescribed PAXLOVID but I did not take it.
only seized twice; chronic leg and back pain are uncomfortable; chronic leg and back pain are uncomfortable; This is a spontaneous report from a Pfizer- sponsored program. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date at dose number unknown, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced seized only twice, the chronic leg and back pain are uncomfortable, but it was worth it. The clinical outcome of the seized only twice, the chronic leg and back pain are uncomfortable were unknown.   No follow-up attempts are possible. Information about lot/batch number were requested.
Itchy red blisters around injection site. Daughter said she hasn't feel well for day or two.
Dizziness, Headache & Arthralgia Narrative:  Other Relevant History:
Shortly after receiving the vaccination pt. complained tightening in thought area. Assessment revealed no obvious signs of edema or anaphylactic incident.  Pt. administered 50mg Benadryl PO.  Pt. monitored 1 hour+ with no changes in condition and no additional complaints.
Sore arm plus nausea, achiness, slight temp, tired, dizzy lasting 24 hours. Still has severe arm pain from shoulder to elbow.
Posterior occipital lymph nodes with rash which occurred 3 wks after MMR/Varivax immunization
Red rashes were noted on his body, would stay for days and then go away. 12/2015 we went to the allergist and labs were drawn.
patient was administered an expired dose of Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient was administered an expired dose of Moderna vaccine) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     Medical history was not provided.     On 27-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient was administered an expired dose of Moderna vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient was administered an expired dose of Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Non-significant follow-up On 28-Sep-2021: Significant follow-up-Expiry date updated
very achy, very dizzy, headache took tylenol and niquil lasted one day and much better the next day
Patient had dizziness and light headedness  10 minutes after receiving the vaccine.  Patient stayed conscious symptoms resolved after elevating feet and receiving water.  Patient stated might have been dehydrated.  No further treatment needed.
Narrative:  COVID infection following COVID vaccine series 02/25 , Pfizer, dose #1 03/17, Pfizer, dose #2 08/09 pt cc: fatigue, exposure: unknown 08/17 pt admit to ED , admit to Medicine, cc: malaise, SOB, Chills dx: COVID-19 complicated with pneumonia and hypoxemia LOS: 5 days 08/16 SARS-COV-2 LINEAGE AY.25 08/16 SARS-COV-2 CLADE 21A DELTA 08/17 COVID swab, result: detected 08/17 PT result: 12.3, APTT result: 35.9, INR result 1.10, ddimer result: 0.50 08/17 LACTIC ACID result: 1.89 08/17 LEGIONELLA ANTIGEN, URINE result: negative 08/18 pt 8/24 pt symptoms continue 08/18 ESR result: 29 08/18 Fibrinogen result: 399 08/18 DDIMER result: 0.34 08/19 ESR result: 17 08/19 Fibrinogen result: 317 08/19 DDIMER result: 0.29 08/20 ESR result: 20 08/20 Fibrinogen result: 267 08/20 DDIMER result: 0.40
Information has been received from a health professional concerning 4 elderly patients who on 29-AUG-2006 were vaccinated with a dose of Pneumovax 23 (lot # 651321/1036P). On 29-AUG-2006 the patients developed swelling, redness and heat in their injection site arms. The patients are being treated with BENADRYL and TYLENOL. It was reported that the physician "is very concerned" about the lot number and therefore has requested a lot check. No further information was available. The reporter considered the patient's experiences to be other important medical events. In follow up information the health professional confirmed that the patient developed swelling, redness and heat in the injection site arm after receiving a dose of Pneumovax 23 (lot # 651321/1036P). She stated that she had no information regarding each patient and stated she was not able to get that information. She said that the doctor told her that all 4 patient's (WAES #'s 0608USA06977, 0609USA05102, and 0609USA05104) had been seen in the office and have since recovered from the swelling, redness and heat in their injection site arms after treatment with BENADRYL and TYLENOL. The health professional was aware that a lot check of concern had been initiated and she stated that she had no further information. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot met the requirements of the Office of Biologics Research and Review and was released by the regulatory agency. Additional information is not expected.
FLU-LIKE SYMPTOMS; CHILLS; MUSCLE ACHES; This spontaneous report received from a parent concerned a 25 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 27-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 27-MAR-2021, the subject experienced flu-like symptoms. On 27-MAR-2021, the subject experienced chills. On 27-MAR-2021, the subject experienced muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, and muscle aches, and the outcome of flu-like symptoms was not reported. This report was non-serious.
no fever;one pox around mouth area;sister had onset of chickenpox 7 days before;both go to same daycare that had 10 cases of chickenpox;no complications and no meds given no hx of pox;
Suspected vaccination failure; Whooping cough; allergies to the Pertussis part of the DPT shot; could not catch breath; This case was reported by a contact via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received DTPa (DTPa vaccine) for prophylaxis.   On an unknown date, the patient received DTPa vaccine at an unknown dose. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), whooping cough (serious criteria GSK medically significant), allergy to vaccine and shortness of breath. On an unknown date, the outcome of the vaccination failure, whooping cough, allergy to vaccine and shortness of breath were unknown.   It was unknown if the reporter considered the vaccination failure, whooping cough, allergy to vaccine and shortness of breath to be related to DTPa vaccine.  Additional case details were reported as follows: This case was reported by the patient's parents. The age at vaccination was not reported. The patient was allergic to the pertussis part of the DPT shot. After vaccination, the patient got whooping cough, which was also passed on to reporter's younger son who had a less serious bout with it. The whooping cough was so scary because the patient would cough so hard he could not catch his breath, if terrified to the patient's parent to be away from him at all.  This case was considered as suspected vaccination failure as details regarding time to onset for target disease, completion of primary vaccination schedule and laboratory confirmation of disease were unknown at the time of reporting. The reporter advised that, get the kids vaccinated, if the parents were able to and whooping cough was nothing to act as if it was no big deal, it was very much so a big deal.
COVID Arm; Very ill; flu like symptoms; unable to move my arm; pain when moving arm; Today is experiencing a really bad bloody nose on the left nose straw for over 25 minutes now and it is ongoing; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Today is experiencing a really bad bloody nose on the left nose straw for over 25 minutes now and it is ongoing), VACCINATION SITE REACTION (COVID Arm), ILLNESS (Very ill), INFLUENZA LIKE ILLNESS (flu like symptoms) and MOBILITY DECREASED (unable to move my arm) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (alergy to codine).    On 22-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Sep-2021, the patient experienced EPISTAXIS (Today is experiencing a really bad bloody nose on the left nose straw for over 25 minutes now and it is ongoing). On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID Arm), ILLNESS (Very ill), INFLUENZA LIKE ILLNESS (flu like symptoms), MOBILITY DECREASED (unable to move my arm) and PAIN (pain when moving arm). At the time of the report, EPISTAXIS (Today is experiencing a really bad bloody nose on the left nose straw for over 25 minutes now and it is ongoing) had not resolved, VACCINATION SITE REACTION (COVID Arm) had resolved and ILLNESS (Very ill), INFLUENZA LIKE ILLNESS (flu like symptoms), MOBILITY DECREASED (unable to move my arm) and PAIN (pain when moving arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Significant follow-up received events and outcome were  added.
Pt received first dose of Moderna Covid-19 vaccine and was asked to sit 15 minutes. After a couple of mins the pt stood up and began to pace the room, at which time I asked the pt if he was ok and he responded that he was fine, but just a few moments later the pt got light headed and fell against the wall. He caught himself, but still hit the side of his head against the wall and this caused a small cut. The pt was immediately moved to sit on the floor with his back against the wall and at this point he seemed to lose conciousness and was moved to lying down. Pts BP was low for several mins, but improved to normal by the time EMS arrived. Pts vitals were checked by EMS and he was cleared to go home with his wife.
Sore left arm on 10/1/10 pt saw PMD for sore arm and was given DARVOCET for pain. 10/8/10 TC from patient stating continued left arm pain an it "pops" when she lifts it up.
I had a bad headache and started with a temp. Then I had some swelling that almost looked like a boil. I was hurting all over and could barely stand up. They say I had cellulities. I was given a booster shot and some antbiotics. I was shaky and could hardly eat,
On 02/08/01, this patient's right upper ext. is swollen, and tender. Prescribed Benadryl, Ice today, then warm compresses tid thereafter.
13 y/o received dose 5/27/21 at 9am. On 5/30/21 noticed red blotches on her trunk and extremities that worsened overnight and became itchy and profuse by 6/1/21. Parents treated her with Benadryl twice and she took cool showers to minimize itching. Double abx ointment applied. Child was taken to an Urgent Care 6/1 in the afternoon and dx with Contact Dermatitis with prescription for a 5 day steroid tapered dose. Reaction is resolving. Father states three other people in the household have received this vaccine, 15 y/o brother at the same clinic, and none have had adverse reaction. Advised to f/u with PCP and determine if second dose should be given. At this time father states she will not be getting the second dose.
Within 5 minutes, writer noted person itching arms, legs, & back. Itching continued for approx. 48 hours. It did not get worse and no additional symptoms developed. Vitals stable.; This is a spontaneous report from a contactable nurse. A 25-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL1284), intramuscularly in the right arm on 29Dec2020 14:00 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  On 29Dec2020, within 5 mins, it was noted the patient had itching arms, legs, & back. Itching continued for approximately 48 hours. It did not get worse and no additional symptoms developed. Vitals were stable. Treatment for the event included benadryl 25mg given per MD with extended monitoring for 2 full hours. The outcome of the event was recovered. It was unknown if patient had covid prior vaccination and unknown if tested for covid post vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Vaccine was administered in a hospital.
This spontaneous report as received from a nurse refers to a patient of unknown demographics. No information about medical history, drug reactions and allergies was specified. On 01-OCT-2014 the patient was vaccinated with PROQUAD (lot # K005644, expiry: 17-OCT-2015, dose 0.5 ml once), subcutaneous that was improperly stored at 6 Fahrenheit for 30 minutes. No concomitant medications were reported. No adverse effects reported. There was no product quality complaint. The outcome is unknown. Additional information has been requested.
testing positive for COVID after receiving vaccine; testing positive for COVID after receiving vaccine; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar event for 14 patients. This is 7th of 14 reports.   An elderly patient (more than 65 years old) of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 13Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced testing positive for COVID after receiving vaccine on 21Jan2021. It was reported that 8 patients and 6 workers at a long term care facility were vaccinated on 13Jan2021 and reported testing positive for COVID on 21Jan2021. Since they were testing positive, physician wanted to administer bamlanirimab (drug being administered under FDA EUA). The event resulted in doctor or other healthcare professional office/clinic visit. Outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the available information, there was  a reasonable possibility that the reported events were related to the suspect product BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE).,Linked Report(s) : US-PFIZER INC-2021063794 same reporter/drug/event, different patient.
Severe stomach cramps. Fever of 104 degrees. Dizziness. Mild chest pain.
Fever, chills, nausea, vomiting for four days after and then sharp chest pain over heart, difficulty breathing, lightheaded state, shortness of breath on day 6 after vaccination and onward
APPROXIMATELY 10 MINUTES AFTER RECEIVING THE VACCINE SHE STATED THAT SHE FELT DIZZY.  WE ASKED HER TO REMAIN SEATED.  SHE STATED SHE FELT LIKE SHE WAS GOING FAINT AND ALSO FELT NAUSEATED AND HOT.  WE GAVE HER WATER THEN SHE LOST CONCIOUSNESS FOR APPROXIMATELY 15 SECONDS.  SHE REGAINED CONSIOUSNESS AND THEN BEGAN TO VOMIT. WE CALLED 911. EMS ARRIVED AND CHECKED HER VITALS AND TOOK HER TO THE HOSPITAL.
Patient reports that 5 hours after her first dose of the moderna covid vaccine she noted itching on her abdomen. The itching then turned into a itchy red rash on the abdomen and back. The rash has lasted 3 weeks but is resolving slowly.
A non-serious spontaneous report of administration of expired FLUMIST was received from a health professional concerning a five-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 04-Dec-2011. On 05-Dec-2011, the patient received expired product. There was no adverse event associated with this medication error; therefore treatment and reporter causality assessments are not applicable, and the event is considered resolved.
My GI doctor had mild heart failure after getting the vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC FAILURE (My GI doctor had mild heart failure after getting the vaccine.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ASKU) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CARDIAC FAILURE (My GI doctor had mild heart failure after getting the vaccine.) (seriousness criterion medically significant). At the time of the report, CARDIAC FAILURE (My GI doctor had mild heart failure after getting the vaccine.) outcome was unknown.            For mRNA-1273 (COVID 19 Vaccine) (unknown route), the reporter did not provide any causality assessments.  No concomitant medication details was reported. No treatment medication details was reported. The patient did not expand on the type of side effects and did not give any further information on this adverse event.  Company comment:  This case concerns a patient of an unknown age and gender with no medical history provided, who experienced a serious unexpected event of Cardiac failure (AES) after the vaccination with mRNA-1273 vaccine. The exact temporal relationship cannot be determined as the start date of the event and date of vaccination was not provided. At the time of the report, the outcome of the event remained unknown and no further information regarding the clinical course of the event was provided. The rechallenge is not applicable as it remained whether adverse event occurred after the first or the second dose. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2021-400097, MOD-2021-400130 (Patient Link).; Sender's Comments: This case concerns a patient of an unknown age and gender with no medical history provided, who experienced a serious unexpected event of Cardiac failure (AES) after the vaccination with mRNA-1273 vaccine. The exact temporal relationship cannot be determined as the start date of the event and date of vaccination was not provided. At the time of the report, the outcome of the event remained unknown and no further information regarding the clinical course of the event was provided. The rechallenge is not applicable as it remained whether adverse event occurred after the first or the second dose. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.
Roughly 30 days after receiving a booster shot of Moderna mRNA COVID 19 vaccine, I developed shingles in the T10 dermatome on the right. Symptoms were at first slow to develop and included change in sensation of the skin the in the affected area, followed several days later by a blistering rash with vesicles in a very dermatomal distribution. My primary care physician confirmed the diagnosis of shingles. I am an otherwise healthy 37yo male with no medical problems.